You are here: Home pathway Area of law pathway Wellbutrin

Defective Drugs Lawyers and Attorneys Legal Help

Wellbutrin

(H1) Risk of Doubling Depression & Suicide for Children Taking Anti-Depressants

Food and Drug Administration (FDA) confirmed publicly that scientific trials of frequently prescribed antidepressants have powerfully demonstrated that children who take Wellbutrin and other anti-depressant medications face increased likelihood of suicide or attempted suicide.

FDA officials said a recent study contracted by the FDA and conducted by Columbia University confirmed the findings of an internal analysis early this year. In clinical trials, the drugs almost doubled the incidence of suicidal behavior in children.

In March of 2004, at public hearings in which parents testified about of the effects of anti-depressants on their children, FDA ordered manufacturers of 10 prescription antidepressants: Prozac, Zoloft, Paxil, Luvox, Celexa, Lexapro, Effexor, Wellbutrin, Serzone and Remeron to include written and packaging warnings about higher risk of deepening depression or even suicide on product labels. The FDA counseled that all families report any behavior change to their caretakers and doctors.

Media and psychiatrists reported links between anti-depressants and teen suicide extensively during 1990.